Edition:
United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

637.70INR
11:24am BST
Change (% chg)

Rs6.45 (+1.02%)
Prev Close
Rs631.25
Open
Rs628.15
Day's High
Rs640.00
Day's Low
Rs628.15
Volume
31,127
Avg. Vol
120,049
52-wk High
Rs664.00
52-wk Low
Rs414.40

Latest Key Developments (Source: Significant Developments)

Alembic Pharmaceuticals Gets FDA Tentative Approval For Alogliptin And Metformin Hydrochloride Tablets
Friday, 14 Sep 2018 

Sept 14 (Reuters) - Alembic Pharmaceuticals Ltd ::ALEMBIC PHARMACEUTICALS -GETS USFDA TENTATIVE APPROVAL FOR ALOGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS, 12.5 MG/500 MG AND 12.5 MG/1000 MG.  Full Article

Alembic Pharmaceuticals Receives Establishment Inspection Report From U.S. FDA
Thursday, 19 Jul 2018 

July 19 (Reuters) - Alembic Pharmaceuticals Ltd ::ALEMBIC PHARMACEUTICALS LTD - HAS RECEIVED ESTABLISHMENT INSPECTION REPORT FROM U.S. FDA FOR INSPECTION CARRIED OUT AT API FACILITY AT KARAKHADI.  Full Article

India's Alembic Pharmaceuticals Gets U.S FDA Tentative Nod For Ticagrelor Tablets
Thursday, 12 Jul 2018 

July 12 (Reuters) - Alembic Pharmaceuticals Ltd ::RECEIVED U.S FDA TENTATIVE APPROVAL FOR TICAGRELOR TABLETS, 90 MG.TABLETS ARE INDICATED TO REDUCE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, OTHERS.  Full Article

Alembic Pharmaceuticals Gets US FDA Nod For Schizophrenia Drug
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Alembic Pharmaceuticals Ltd ::RECEIVED US FDA TENTATIVE APPROVAL FOR ILOPERIDONE TABLETS.SAYS LLOPERIDONE TABLETS ARE INDICATED FOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTS.  Full Article

Alembic Pharmaceuticals March-Qtr Net Profit Rises
Wednesday, 16 May 2018 

May 16 (Reuters) - Alembic Pharmaceuticals Ltd ::RECOMMENDED FINAL DIVIDEND OF 4 RUPEES PER SHARE.MARCH QUARTER CONSOL NET PROFIT 937.9 MILLION RUPEES VERSUS PROFIT 930.4 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 8.53 BILLION RUPEES VERSUS 7.41 BILLION RUPEES YEAR AGO.  Full Article

Alembic Pharmaceuticals' Panelav Unit Gets Zero 483 Observations From U.S. FDA
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Alembic Pharmaceuticals Ltd ::SUCCESSFUL U.S. FDA INSPECTION AT API FACILITY AT PANELAV.THERE WERE ZERO 483 OBSERVATIONS AT THE FACILITY.  Full Article

Alembic Pharmaceuticals Says U.S. FDA Grants Orphan-Drug Designation To Rhizen Pharmaceuticals
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Alembic Pharmaceuticals Ltd ::U.S. FDA GRANTS ORPHAN-DRUG DESIGNATION FOR TENALISIB TO RHIZEN PHARMACEUTICALS S.A. (RHIZEN).  Full Article

Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Alembic Pharmaceuticals Ltd ::GETS U.S. FDA NOD FOR DARIFENACIN EXTENDED-RELEASE TABLETS.DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER.  Full Article

India's Alembic Pharma Sept-qtr consol PAT rises
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Alembic Pharmaceuticals Ltd ::Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​.Sept quarter consol PAT 1.22 billion rupees versus 1.20 billion rupees year ago.Sept quarter consol revenue from operations 7.89 billion rupees versus 8.79 billion rupees year ago.  Full Article

Alembic Pharma buys generic drug developer Orit Laboratories
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Alembic Pharmaceuticals Ltd ::Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​.  Full Article

BRIEF-Alembic Pharmaceuticals' Panelav Unit Gets Zero 483 Observations From U.S. FDA

* THERE WERE ZERO 483 OBSERVATIONS AT THE FACILITY Source text - https://bit.ly/2Hl7Sul Further company coverage: